Evotec achieves further milestones in TargetAD collaboration with Janssen

  • Evotec AG today announced the achievement of several small, but very important milestones in its TargetAD collaboration with Janssen Pharmaceuticals, Inc. for the identification and selection of novel targets from Evotec’s TargetAD database and for the transition of targets into the drug discovery process. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-achieves-further-milestones-in-targetad-collaboration-with-janssen-5263

    Du magst vielleicht auch